Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation

被引:4
|
作者
Ma, Ying-Qian [1 ,2 ]
Zhang, Ming [1 ,5 ]
Sun, Zhen-Hua [1 ]
Tang, Hong-Yue [3 ]
Wang, Ying [2 ]
Liu, Jiang-Xue [2 ]
Zhang, Zhan-Xue [4 ]
Wang, Chao [3 ]
机构
[1] Hebei Gen Hosp, Dept Oncol, Shijiazhuang 050051, Hebei, Peoples R China
[2] Hebei Med Univ, Sch Grad Studies, Shijiazhuang 050017, Hebei, Peoples R China
[3] Hebei Gen Hosp, Clin Med Res Ctr, Shijiazhuang 050051, Hebei, Peoples R China
[4] Hebei Med Univ, Hosp 2, Dept Gastrointestinal Surg, Shijiazhuang 050000, Hebei, Peoples R China
[5] Hebei Gen Hosp, Dept Oncol, 348 Heping West Rd, Shijiazhuang 050051, Hebei, Peoples R China
关键词
Resveratrol; Gastric cancer; Network pharmacology; Bioinformatics; Molecular docking; CELL-CYCLE; C-FOS; PROLIFERATION; INHIBITORS; PROTEIN;
D O I
10.4251/wjgo.v16.i2.493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND Gastric cancer (GC) is one of the most aggressive malignancies with limited therapeutic options and a poor prognosis. Resveratrol, a non-flavonoid polyphenolic compound found in a variety of Chinese medicinal materials, has shown excellent anti-GC effect. However, its exact mechanisms of action in GC have not been clarified. AIM To identify the effects of resveratrol on GC progression and explore the related molecular mechanisms. METHODS Action targets of resveratrol and GC-related targets were screened from public databases. The overlapping targets between the two were confirmed using a Venn diagram, and a "Resveratrol-Target-GC" network was constructed using Cytoscape software version 3.9.1. The protein-protein interaction (PPI) network was constructed using STRING database and core targets were identified by PPI network analysis. The Database for Annotation, Visualization and Integrated Discovery database was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. A "Target-Pathway" network was created by using Cytoscape 3.9.1. The RNA and protein expression levels of core target genes were observed using the Cancer Genome Atlas and the Human Protein Atlas databases. DriverDBv3 and Timer2.0 databases were used for survival and immune infiltration analysis. Subsequently, the findings were further verified by molecular docking technology and in vitro experiments. RESULTS A total of 378 resveratrol action targets and 2154 GC disease targets were obtained from public databases, and 181 intersection targets between the two were screened by Venn diagram. The top 20 core targets were identified by PPI network analysis of the overlapping targets. GO function analysis mainly involved protein binding, identical protein binding, cytoplasm, nucleus, negative regulation of apoptotic process and response to xenobiotic stimulus. KEGG enrichment analysis suggested that the involved signaling pathways mainly included PI3K-AKT signaling pathway, MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, ErbB signaling pathway, etc. FBJ murine osteosarcoma viral oncogene homolog (FOS) and matrix metallopeptidase 9 (MMP9) were selected by differential expression analysis, and they were closely associated with immune infiltration. Molecular docking results showed that resveratrol docked well with these two targets. Resveratrol treatment arrested the cell cycle at the S phase, induced apoptosis, and weakened viability, migration and invasion in a dose-dependent manner. Furthermore, resveratrol could exhibit anti-GC effect by regulating FOS and MMP9 expression. CONCLUSION The anti-GC effects of resveratrol are related to the inhibition of cell proliferation, migration, invasion and induction of cell cycle arrest and apoptosis by targeting FOS and MMP9.
引用
收藏
页码:493 / 513
页数:22
相关论文
共 50 条
  • [21] Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
    Jiang, Yunzhong
    Zhang, Mengzhao
    Wang, Lu
    Zhang, Lu
    Ma, Minghai
    Jing, Minxuan
    Li, Jianpeng
    Song, Rundong
    Zhang, Yuanquan
    Yang, Zezhong
    Zhang, Yaodong
    Pu, Yuanchun
    Qu, Xiaowei
    Fan, Jinhai
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [22] Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
    Yunzhong Jiang
    Mengzhao Zhang
    Lu Wang
    Lu Zhang
    Minghai Ma
    Minxuan Jing
    Jianpeng Li
    Rundong Song
    Yuanquan Zhang
    Zezhong Yang
    Yaodong Zhang
    Yuanchun Pu
    Xiaowei Qu
    Jinhai Fan
    BMC Complementary Medicine and Therapies, 23
  • [23] Combining Network Pharmacology, Molecular Docking and Experimental Validation to Explore the Effects and Mechanisms of Indirubin on Acute Lymphoblastic Leukemia
    Jin, Lu
    Guan, Yunshuang
    Li, Xue
    Wang, Mingyue
    Shen, Ying
    Wang, Nianxue
    He, Zhixu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1083 - 1103
  • [24] Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation
    Wang, Shou-Jia
    Ye, Wen
    Li, Wan-Yi
    Tian, Wen
    Zhang, Meng
    Sun, Yang
    Feng, Ying-Da
    Liu, Chen-Xu
    Liu, Shao-Yuan
    Cao, Wei
    Meng, Jing-Ru
    Li, Xiao-Qiang
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 303
  • [25] A network pharmacology-based investigation of the mechanism involved in the anti-gastric cancer effect of gastric cancer effect of Oldenlandia diffusan, a traditional Chinese medicine
    Ma, Zhenchi
    Zhao, Peng
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (12) : 2625 - 2632
  • [26] Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
    Gong, Zhaohui
    Yang, Haixin
    Gao, Li
    Liu, Yi
    Chu, Qingmin
    Luo, Chuanjin
    Kang, Liang
    Zhai, Huiqi
    Xu, Qiang
    Wu, Wei
    Li, Nan
    Li, Rong
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2025, 25 (01)
  • [27] Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis
    Cao, Ling
    Chen, Yan
    Zhang, Miao
    Xu, De-quan
    Liu, Yan
    Liu, Tonglin
    Liu, Shi-xin
    Wang, Ping
    PEERJ, 2018, 6
  • [28] Network pharmacology study and in vitro experimental validation of Xiaojianzhong decoction against gastric cancer
    Chen, Guo-Qing
    Nan, Yi
    Ning, Na
    Huang, Shi-Cong
    Bai, Yu-Ting
    Zhou, Zi-Ying
    Qian, Gu
    Li, Wei-Qiang
    Yuan, Ling
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (09)
  • [29] The mechanism of polyphyllin in the treatment of gastric cancer was verified based on network pharmacology and experimental validation
    Lu, Doudou
    Yuan, Ling
    Ma, Xiaoyan
    Meng, Fandi
    Xu, Duojie
    Jia, Shumin
    Wang, Zhaozhao
    Li, Yahong
    Zhang, Zhe
    Nan, Yi
    HELIYON, 2024, 10 (10)
  • [30] Identification of the Mechanism of Action of the Index Components of Banxia Xiexin Decoction for Gastric Cancer through Network Pharmacology, Bioinformatics, and Molecular Docking Analysis
    Niu, Xiaoji
    Ma, Mingyue
    Wang, Shoumei
    Hu, Aiyan
    Xu, Yi
    Zhu, Liang
    Zhang, Shuhui
    JOURNAL OF CHEMISTRY, 2024, 2024